Related Experiment Video
Updated: Aug 18, 2025

Isolation of Lipoprotein Particles from Chicken Egg Yolk for the Study of Bacterial Pathogen Fatty Acid Incorporation into Membrane Phospholipids
Published on: May 15, 2019
Interference with Lipoprotein Maturation Sensitizes Methicillin-Resistant Staphylococcus aureus to Human Group
Marieke M Kuijk1, Yongzheng Wu2, Vincent P van Hensbergen3
1Medical Microbiology and Infection Prevention, Amsterdam University Medical Centers, Location University of Amsterdam, Amsterdam, The Netherlands, marieke@kuijknet.nl.
Abstract:
Methicillin-resistant Staphylococcus aureus (MRSA) has been classified as a high priority pathogen by the World Health Organization underlining the high demand for new therapeutics to treat infections. Human group IIA-secreted phospholipase A2 (hGIIA) is among the most potent bactericidal proteins against Gram-positive bacteria, including S. aureus. To determine hGIIA-resistance mechanisms of MRSA, we screened the Nebraska Transposon Mutant Library using a sublethal concentration of recombinant hGIIA. We identified and confirmed the role of lspA, encoding the lipoprotein signal peptidase LspA, as a new hGIIA resistance gene in both in vitro assays and an infection model in hGIIA-transgenic mice. Increased susceptibility of the lspA mutant was associated with enhanced activity of hGIIA on the cell membrane. Moreover, lspA deletion increased susceptibility to daptomycin, a last-resort antibiotic to treat MRSA infections. MRSA wild type could be sensitized to hGIIA and daptomycin killing through exposure to LspA-specific inhibitors globomycin and myxovirescin A1. Analysis of >26,000 S. aureus genomes showed that LspA is highly sequence-conserved, suggesting universal application of LspA inhibition. The role of LspA in hGIIA resistance was not restricted to MRSA since Streptococcus mutans and Enterococcus faecalis were also more hGIIA-susceptible after lspA deletion or LspA inhibition, respectively. Overall, our data suggest that pharmacological interference with LspA may disarm Gram-positive pathogens, including MRSA, to enhance clearance by innate host defense molecules and clinically applied antibiotics.
Insights
New research reveals that inhibiting lipoprotein signal peptidase A (LspA) can resensitize methicillin-resistant Staphylococcus aureus (MRSA) to host defenses and antibiotics. This finding offers a promising strategy against high-priority MRSA infections.
Area of Science:
- Microbiology and Infectious Diseases
- Drug Discovery and Development
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) is a high-priority pathogen requiring novel therapeutics.
- Human group IIA-secreted phospholipase A2 (hGIIA) exhibits potent bactericidal activity against Gram-positive bacteria, including S. aureus.
Purpose of the Study:
- To identify mechanisms by which MRSA develops resistance to hGIIA.
- To explore LspA as a potential therapeutic target for enhancing MRSA susceptibility.
Main Methods:
- Screening of the Nebraska Transposon Mutant Library for hGIIA resistance genes.
- In vitro assays and infection models in hGIIA-transgenic mice to confirm the role of lspA.
- Analysis of over 26,000 S. aureus genomes for LspA conservation.
- Testing the efficacy of LspA-specific inhibitors (globomycin, myxovirescin A1).
Main Results:
- Lipoprotein signal peptidase A (LspA) was identified as a novel hGIIA resistance gene in MRSA.
- lspA deletion increased MRSA susceptibility to hGIIA and daptomycin, a last-resort antibiotic.
- LspA inhibition sensitized MRSA, Streptococcus mutans, and Enterococcus faecalis to hGIIA and daptomycin.
- LspA is highly conserved across S. aureus strains, indicating broad applicability.
Conclusions:
- Pharmacological inhibition of LspA can disarm Gram-positive pathogens, including MRSA.
- Targeting LspA enhances the efficacy of innate host defense molecules and existing antibiotics.
- LspA inhibition represents a promising strategy to combat challenging Gram-positive bacterial infections.
Related Concept Videos
Formation of Lipopolysaccharides
Development of Antibiotic Resistance
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Mismatch Repair
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Inflammation

